According to the current analysis of Reports and Data, the global Immunohematology market was valued at USD 1.66 billion in 2018 and is expected to reach USD 2.45 billion by the year 2026, growing at a CAGR of 5.0%. Immunohematology is a branch of “Hematology,” which facilitates the screening of donor blood for antigens, Rh factor, and other blood components such as white blood cells. Commonly known as “Blood Banking,” it prepares blood components for transfusion and helps in reducing transfusion-related diseases such as HIV and thalassemia.
Immunohematology enables safe blood transfusion and transplantation of hematopoietic tissue, as well as prevent the undesired immune-related complications, transplantation, and pregnancy-related issues. High incidence of hematological diseases, increasing demand for platelets, plasma factors, and immunoglobin, the rapid development of blood banks by government and private institutions, and increased awareness regarding the importance of blood-transfusion related diseases are some of the key factors propelling the market growth.
Technological advancements in the immunohematology devices include fully automated analyzers that perform the blood screening test and deliver speedy & accurate results. The technological advances have significantly improved the clinical outcomes and helped increasing reliability and accuracy. Such advancements have enabled the end-users to adopt a vitro study of blood compatibility between the receiver’s and donor’s blood. Advanced antiglobulin screening instruments and assays validate for proper blood typing. Key market players are significantly investing in Research & Development and product innovation. Furthermore, the companies are focusing on improving the safety and longevity of blood stored in blood banks by innovating advanced immunohematology devices.
The upcoming market trend is of Reagent rentals or leasing analyzers. However, considering that the high costs of the analyzers and of reagents are reducing the sales of immunohematology devices, manufacturers are permitting the end-users to rent the advanced reagents and analyzers. The biggest problems hampering the market growth is the availability of the truly voluntary altruistic blood donor. Despite, screening for transfusion transmissible diseases is now widespread although there is still a scope and requirement to enhance quality assurance procedures and to improve the outcome. Lack of awareness and shortage of skilled professionals to carry out the process are some of the major hindrances to the immunohematology market during the forecast period.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2251
The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.
Key companies operating in the market include:
Siemens Healthcare GmbH, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Grifols, Immucor, Abbott laboratories, Beckman Coulter, ThermoFisher, Becton Dickinson and Merck KGaA
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2251
The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Immunohematology market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
On basis of product types and application offered by the Immunohematology industry, the market is segmented into:
Product (Revenue, USD Million; 2016–2026)
- Immunohematology Reagents
- Immunohematology Analyzers
- Automated Analyzers
- Semi-automated analyzers / Non-automated analyzers
Application (Revenue, USD Million; 2016–2026)
- Pretransfusion testing
- ABO and Rh Typing
- Antibody Detection
- Cross matching
- Investigation of immune hemolysis
- Perinatal testing
- Blood group Phenotyping / genotyping
- Leucocyte and platelet Serology
Disease (Revenue, USD Million; 2016–2026)
- Blood-related diseases
End-use (Revenue, USD Million; 2016–2026)
- Blood banks
- Diagnostic laboratories
The regional analysis covers:
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/immunohematology-market
Benefits of Immunohematology Market Report:
- Panoramic overview of the opportunities and risks in the Immunohematology sector
- Study of recent innovations and developments in the industry
- Comprehensive study of the growth pattern of the Immunohematology industry
- In-depth assessment of the competitive landscape of the key players of the Immunohematology industry
- Analysis of the Immunohematology market drivers, constraints, and opportunities
- Assessment of technological developments and latest trends of the industry
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2251
Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.
Browse More Reports :
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]